Literature DB >> 15950902

CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.

Patrick Michl1, Antoine R Ramjaun, Olivier E Pardo, Patricia H Warne, Martin Wagner, Richard Poulsom, Corrado D'Arrigo, Kenneth Ryder, Andre Menke, Thomas Gress, Julian Downward.   

Abstract

CUTL1, also known as CDP, Cut, or Cux-1, is a homeodomain transcriptional regulator known to be involved in development and cell cycle progression. Here we report that CUTL1 activity is associated with increased migration and invasiveness in numerous tumor cell lines, both in vitro and in vivo. Furthermore, we identify CUTL1 as a transcriptional target of transforming growth factor beta and a mediator of its promigratory effects. CUTL1 activates a transcriptional program regulating genes involved in cell motility, invasion, and extracellular matrix composition. CUTL1 expression is significantly increased in high-grade carcinomas and is inversely correlated with survival in breast cancer. This suggests that CUTL1 plays a central role in coordinating a gene expression program associated with cell motility and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950902     DOI: 10.1016/j.ccr.2005.05.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  69 in total

1.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.

Authors:  Mary Truscott; Ryoko Harada; Charles Vadnais; François Robert; Alain Nepveu
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

3.  CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase.

Authors:  Laetitia Seguin; Caroline Liot; Rym Mzali; Ryoko Harada; Aurelie Siret; Alain Nepveu; Jacques Bertoglio
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

4.  TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells.

Authors:  Jing Wang; Jian Chen; Kailiang Zhang; Yuan Zhao; Jacques E Nör; Junzheng Wu
Journal:  J Oral Pathol Med       Date:  2011-06-21       Impact factor: 4.253

Review 5.  Wnt5a as an effector of TGFβ in mammary development and cancer.

Authors:  Rosa Serra; Stephanie L Easter; Wen Jiang; Sarah E Baxley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-18       Impact factor: 2.673

6.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

7.  Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer.

Authors:  Tingting Li; Honghong Wang; Yimin Sun; Lina Zhao; Yi Gang; Xuegang Guo; Rei Huang; Zhiping Yang; Yanglin Pan; Kaichun Wu; Li Xu; Zhiguo Liu; Daiming Fan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.

Authors:  Sabine Topka; Alexander Glassmann; Gunnar Weisheit; Ulrich Schüller; Karl Schilling
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

9.  The transcription factor Cux1 regulates dendritic morphology of cortical pyramidal neurons.

Authors:  Ning Li; Chun-Tao Zhao; Ying Wang; Xiao-Bing Yuan
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

10.  Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.

Authors:  Rania Siam; Ryoko Harada; Chantal Cadieux; Robert Battat; Charles Vadnais; Alain Nepveu
Journal:  Mol Cancer       Date:  2009-08-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.